Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: June 2019
This action brief provides rural communities recommended strategies for adapting promising or proven interventions to better support crisis response and pre-arrest diversion in their communities. It is the first of three briefs developed from the SAMHSA Pre-Arrest Diversion Expert Panel.